ImmunoMolecular Therapeutics Inc. has raised $10 million to develop drugs that stop the progression of Type 1 diabetes and other autoimmune diseases.
Biotech companies are seeking new treatments for Type 1 diabetes, a condition in which the immune system destroys insulin-making cells. Patients now manage the disease by taking insulin.
Vertex...
Our Intelligence. Your Advantage.
Sign in or subscribe for access to peerless insight & analysis, curated data & interactives, and networking events.
